WESTWOOD, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- Corza Medical
(https://corza.com/) ("Corza" or the "Company") is proud to announce the
appointment of Derek Chaves as its new Chief Financial Officer (CFO), effective
July 8, 2024. Corza Medical, a rapidly growing global leader in medical
technology and innovative surgical solutions, is recognized for its
comprehensive approach to excellence in customer service and partnerships.
Derek's appointment underscores Corza's commitment to scaling operations and
driving further growth in a complex and dynamic market landscape.
Derek brings over 25 years of broad experience in finance and accounting within
the medical technologies and life sciences sectors, including roles of
increasing responsibility at C.R. Bard, later acquired by Becton Dickinson. Most
recently, Derek served as Vice President, Finance for the $3.6B Integrated
Diagnostic Solutions global business unit at Becton Dickinson and previously
held the role of VP, Finance for Becton Dickinson's global Surgery business
unit.
"Derek's appointment comes at a pivotal time for Corza Medical as we have
surpassed the half-billion revenue threshold and continue to innovate and expand
our capabilities," said Gregory T. Lucier
(https://www.linkedin.com/in/greglucier/), Corza Medical Executive Chairman.
"His global experience in finance, understanding of the complexities of our
industry, and his proven track record supporting rapid growth while ensuring
operational efficiencies will be instrumental in our future success."
"Derek's deep expertise across medical device and pharmaceutical operations
uniquely qualifies him to drive value creation as we expand our global footprint
and enhance our offerings. He is an invaluable addition to our executive team,"
added Tom Testa (https://www.linkedin.com/in/tbtesta/), Corza Medical's Chief
Executive Officer.
Derek holds a Bachelor of Science in Business Administration from Bryant
University and a Master of Business Administration from Charleston Southern
University. His comprehensive background and leadership skills will play a
crucial role in Corza Medical's ongoing success and mission to deliver cutting-
edge solutions to healthcare professionals worldwide through remarkable service,
trusted performance, and outstanding value.
About Corza Medical
Corza Medical is a leading global manufacturer of innovative surgical
technologies. With a global team of over 3,000 employees supporting clinicians,
distributor-partners, and medical device companies worldwide, Corza provides
healthcare professionals a platform of surgical technologies with many industry-
leading brands, including Quill® barbed sutures, Sharpoint® Plus and Look(TM)
surgical sutures, Katena® reusable and Blink(TM) single-use ophthalmic instruments,
Barron corneal transplant devices, Sharpoint® microsurgical knives, and the
TachoSil® fibrin sealant patch. For more information, please visit www.corza.com
(http://www.corza.com/).
Â